ArticleAnnals of hematology2025

Promising activity of Selinexor in the treatment of a patient with refractory NUP98-NSD1+/FLT3-ITD + acute myeloid leukemia.

Kun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.